TF-1 is a human hematopoietic cell line derived from the bone marrow of a patient with erythroleukemia. The TF-1 cell line was established in the 1970s and has since been widely used in hematological and cancer research. TF-1 cells have characteristics of erythroid progenitor cells and can differentiate into various hematopoietic lineages, making them valuable for studying hematopoiesis, erythropoiesis, and leukemia development.
TF-1 cells have been utilized to investigate the molecular mechanisms underlying hematopoietic differentiation, proliferation, and survival, as well as to screen potential anti-leukemia drugs and therapies. These cells have contributed to our understanding of blood cell biology, leukemia pathogenesis, and the development of targeted treatments for hematological malignancies.
Organism species: Homo sapiens (Human)
| CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
| Cells | CSI339Hu11 | Human TF-1 Pure Erythroid Leukemia Cells (TF-1) | TF-1 cells can be used to investigate the molecular mechanisms underlying hematopoietic differentiation, proliferation, and survival, as well as to screen potential anti-leukemia drugs and therapies. |
| Extracts | n/a | Extract of TF-1 Pure Erythroid Leukemia Cells (TF-1) | Total Protein/DNA/RNA Extract Customized Service Offer |
| Mediums | MSI339Hu11 | Medium for Human TF-1 Pure Erythroid Leukemia Cells (TF-1) | Complete Medium for the culture of TF-1 cell line |